The demographics of patients diagnosed with vaccine-associated rejection post-SARS-CoV-2 vaccination
| Frequency (n) | % | |
| Patients/eyes | 46/55 | |
| Mean age (in years) | 62.76±15.83 | |
| Age | ||
| 20–29 | 2 | 4.35 |
| 30–39 | 1 | 2.17 |
| 40–49 | 7 | 15.22 |
| 50–59 | 5 | 10.87 |
| 60–69 | 10 | 21.74 |
| 70–79 | 10 | 21.74 |
| 80–89 | 6 | 13.05 |
| 90–99 | 1 | 2.17 |
| Unknown | 4 | 8.69 |
| Sex | ||
| Female | 28 | 60.87 |
| Male | 16 | 34.78 |
| Unknown | 2 | 4.35 |
| Type of corneal transplantation | ||
| PK | 34 | 61.82 |
| DMEK | 7 | 12.73 |
| DSEK | 10 | 18.18 |
| EK (uncategorized) | 1 | 1.82 |
| ALK | 2 | 3.64 |
| CLAT | 1 | 1.82 |
| Laterality | ||
| Unliteral | 37 | 80.43 |
| Bilateral | 9 | 19.57 |
| Type of vaccine | ||
| BNT162b2 | 34 | 73.91 |
| mRNA-1273 | 12 | 26.09 |
| Dosage | ||
| 1 | 17 | 36.96 |
| 2 | 21 | 45.65 |
| 3 | 2 | 4.35 |
| Unknown | 6 | 13.04 |
| Onset interval postvaccination | ||
| Hyperacute (day 0) | 1 | 2.17 |
| Acute (days 1–7) | 10 | 21.74 |
| Delayed (> 7 days) | 31 | 67.39 |
| Unknown | 4 | 8.70 |
ALK, anterior lamellar keratoplasty; CLAT, Corneal Limbal Allograft Transplantation; DMEK, descemet membrane endothelial keratoplasty; DSEK, descemet stripping endothelial keratoplasty; EK, endothelial keratoplasty; PK, penetrating keratoplasty.